SVB Wealth LLC Purchases Shares of 4,992 Henry Schein, Inc. (NASDAQ:HSIC)

SVB Wealth LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 4,992 shares of the company’s stock, valued at approximately $345,000.

Other institutional investors have also modified their holdings of the company. ING Groep NV purchased a new position in shares of Henry Schein in the 3rd quarter valued at $63,226,000. Holocene Advisors LP purchased a new position in shares of Henry Schein during the third quarter worth about $58,319,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Henry Schein during the third quarter worth about $43,740,000. Southpoint Capital Advisors LP lifted its holdings in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after purchasing an additional 558,689 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on HSIC. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Down 0.7 %

Shares of Henry Schein stock opened at $70.31 on Wednesday. The firm has a market cap of $8.73 billion, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The company’s 50-day simple moving average is $74.41 and its 200-day simple moving average is $72.51. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the firm posted $0.66 EPS. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.